Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Medi-Port Pilot Randomized Controlled Trial

NCT02611739 · The Hospital for Sick Children · Updated 3 Jan 2018

What is being tested
Medi-Port; Medi-Port
For
Actively Undergoing Cancer Treatment; 4-9 Years of Age; At Least 1 Month From Diagnosis; Able to Speak and Understand English; Presenting to Clinic for at Least a 2nd Subcutaneous Port Needle Insertion
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 4 years to 9 years. About 40 people. The full rules are on the registry page.
Where
Canada
When
Starts or started Jan 2016, ends Dec 2016. Registered 23 Nov 2015.
Results
None posted yet.

In the researchers' words

Pain is a frequent and significant problem related to cancer-directed treatment in children. Children with cancer often cite needle procedures as the most distressing experience caused by cancer and its treatment. Recently it has been shown that an interactive humanoid robot is capable of facilitating distraction and reducing distress during childhood immunizations. Our research objectives are to: (1) assess the feasibility of implementing the robot (Medi-Port) for effectiveness testing in a future RCT (measured as implementation outcomes) and (2) determine treatment effectiveness estimates (measured as preliminary effectiveness outcomes), compared to standard medical care.
ClinicalTrials.gov, NCT02611739

Sites

  • Hospital for Sick ChildrenToronto, Ontario, Canada